Showing 2041-2050 of 3223 results for "".
- Allergan Announces REFRESH Concierge Program for ECPshttps://modernod.com/news/allergan-announces-refresh-concierge-program-for-ecps/2478382/Allergan announced the launch of its REFRESH Concierge service. The REFRESH Concierge is a full-service, dedicated remote support team providing eye care professionals with: Patient coupons Product education Help creating a REFRESH Direct eCommerce online sto
- Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practiceshttps://modernod.com/news/alcon-to-showcase-innovations-at-academy20-that-support-recovery-and-growth-for-eye-care-practices/2478379/Alcon will highlight leading innovations and clinical research at the 2020 American Academy of Optometry (#Academy20) meeting taking place virtually from October 7-22, 2020. The company’s virtual program will feature updates on its most important innovations, including Precision1 one-day contact
- American Academy of Optometry Foundation Announces the 2020-2021 Allergan Foundation Research Grant Recipientshttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2020-2021-allergan-foundation-research-grant-recipients/2478375/The American Academy of Optometry Foundation (AAOF), in partnership with the Allergan Foundation, has announced two grant recipients this year in the areas of the anterior segment and glaucoma. The recipient of the Allergan Foundation Grant in the area of the anterior segment is Suzanne MJ
- In Memoriam: Alan S. Crandall, MDhttps://modernod.com/news/renowned-ophthalmologist-and-humanitarian-alan-s-crandall-md-dies-at-age-73/2478360/Alan S. Crandall, MD, arguably known most for his humanitarian efforts spanning a career of nearly 40 years, died October 2 following a sudden illness. Dr. Crandall practiced at the John A. Moran Eye Center at University of Utah Health for 39 years. Most recently, he served as presidential profes
- Alcon Focuses on Presbyopia-Correcting IOL Innovation and the New Normal at the Virtual ESCRS 2020https://modernod.com/news/alcon-focuses-on-presbyopia-correcting-iol-innovation-and-the-new-normal-at-the-virtual-escrs-2020/2478344/Alcon will host several events and present new technologies in cataract surgery during the virtual European Society of Cataract and Refractive Surgery (ESCRS) 2020 annual meeting, taking place October 2-4. “As
- FDA Approves Bausch + Lomb Alaway Preservative Free OTC Dropshttps://modernod.com/news/fda-approves-bausch-lomb-alaway-preservative-free-ophthalmic-solution/2478329/Bausch + Lomb and Eton Pharmaceuticals announced that the FDA has approved Alaway Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100), as the first over-the-counter (OTC) preservative-free formulation eye drop approved to temporarily relieve itchy
- Alsanza Announces Launch of Alsafit Fourier Optic IOLhttps://modernod.com/news/alsanza-announces-launch-of-alsafit-fourier-optic-iol/2478312/Alsanza announced the launch of the Alsafit Fourier Optic presbyopia correcting IOL. The optic structure of the Fourier Optic is free of sharp edges on the optic surface and features the first reverse apodized optic that benefits dynamic light distribution, according to a company news rele
- Bausch Health Acquires Option To Purchase Ophthalmology Assets Of Allegro Ophthalmicshttps://modernod.com/news/bausch-health-to-acquire-option-to-purchase-all-ophthalmology-assets-of-allegro-ophthalmics/2478300/Bausch Health has entered into an agreement to acquire an option to purchase all ophthalmology assets of Allegro Ophthalmics, including global rights for risuteganib (Luminate)1, Allegro’s lead investigational compound in retina. Full financial terms of the deal were not d
- FDA Probes Whether to Allow AstraZeneca to Resume COVID-19 Vaccine Trial in UShttps://modernod.com/news/fda-probes-whether-to-allow-astrazeneca-to-resume-covid-19-vaccine-trial-in-us/2478286/The FDA is looking into whether they should follow their UK counterparts in allowing a phase 3 study of AstraZeneca’s COVID-19 vaccine to resume after it had been temporarily suspended last week when a trial participant in the UK was said to have suffered spinal cord inflammation. AstraZene
- LumiThera and Diopsys Announce Collaboration and Enrollment of First Subject in the ELECTROLIGHT Study in Dry AMD Patientshttps://modernod.com/news/lumithera-and-diopsys-announce-collaboration-and-enrollment-of-first-subject-in-the-electrolight-study-in-dry-amd-patients/2478265/LumiThera announced it is collaborating with Diopsys, a provider of modern visual electrophysiology solutions. Diopsys’ technology helps eye care professionals accurately and objectively measure retinal and visual pathway function. The joint effort supports a prospective, pilot, huma